GB9713484D0 - Neuroprotective vanilloid compounds - Google Patents

Neuroprotective vanilloid compounds

Info

Publication number
GB9713484D0
GB9713484D0 GBGB9713484.5A GB9713484A GB9713484D0 GB 9713484 D0 GB9713484 D0 GB 9713484D0 GB 9713484 A GB9713484 A GB 9713484A GB 9713484 D0 GB9713484 D0 GB 9713484D0
Authority
GB
United Kingdom
Prior art keywords
neuroprotective
vanilloid compounds
vanilloid
compounds
neuroprotective vanilloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9713484.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9713484.5A priority Critical patent/GB9713484D0/en
Publication of GB9713484D0 publication Critical patent/GB9713484D0/en
Priority to EP98936402A priority patent/EP1003491A1/en
Priority to JP50529699A priority patent/JP2002511866A/en
Priority to CA002295089A priority patent/CA2295089A1/en
Priority to PCT/EP1998/004005 priority patent/WO1999000115A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
GBGB9713484.5A 1997-06-27 1997-06-27 Neuroprotective vanilloid compounds Pending GB9713484D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9713484.5A GB9713484D0 (en) 1997-06-27 1997-06-27 Neuroprotective vanilloid compounds
EP98936402A EP1003491A1 (en) 1997-06-27 1998-06-18 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases
JP50529699A JP2002511866A (en) 1997-06-27 1998-06-18 Use of an antagonist or partial agonist of the vanilloid receptor complex for the treatment of neurodegenerative diseases
CA002295089A CA2295089A1 (en) 1997-06-27 1998-06-18 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases
PCT/EP1998/004005 WO1999000115A1 (en) 1997-06-27 1998-06-18 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713484.5A GB9713484D0 (en) 1997-06-27 1997-06-27 Neuroprotective vanilloid compounds

Publications (1)

Publication Number Publication Date
GB9713484D0 true GB9713484D0 (en) 1997-09-03

Family

ID=10814943

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9713484.5A Pending GB9713484D0 (en) 1997-06-27 1997-06-27 Neuroprotective vanilloid compounds

Country Status (5)

Country Link
EP (1) EP1003491A1 (en)
JP (1) JP2002511866A (en)
CA (1) CA2295089A1 (en)
GB (1) GB9713484D0 (en)
WO (1) WO1999000115A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444440B1 (en) 1997-03-07 2002-09-03 Human Genome Sciences, Inc. Vanilloid receptor-2
US6906178B2 (en) 1998-08-11 2005-06-14 Human Genome Sciences, Inc. Vanilloid receptor-2
JP3501775B2 (en) * 2000-05-31 2004-03-02 ファイザー株式会社 Human vanilloid receptor-like protein
DE60120421T2 (en) * 2000-08-21 2006-12-28 Pacific Corp. NEW (THIO) UREA CONNECTIONS AND MEDICINAL COMPOSITIONS CONTAINING THEM
AU2001280229B2 (en) 2000-08-21 2006-12-07 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
KR100433940B1 (en) * 2000-08-22 2004-06-04 주식회사 뉴로넥스 Pharmaceutical Composition for Prevention and Treatment of Rheumatic Arthritis or Allergic Diseases Comprising Capsazepine with Inhibitory Activity of PAF receptor as Active Ingredient
JP2005506037A (en) * 2000-12-01 2005-03-03 ブリストル−マイヤーズ　スクイブ　カンパニー Novel human nucleic acid molecules and polypeptides encoding novel human ion channels expressed in the spinal cord and brain
JP5384777B2 (en) * 2001-12-18 2014-01-08 有限会社大長企画 Strong muscle agent, anti-inflammatory agent
TW200406390A (en) 2002-01-17 2004-05-01 Neurogen Corp Substituted quinazolin-4-ylamine analogues
NZ536418A (en) 2002-05-08 2006-04-28 Bayer Healthcare Ag Hydroxy tetrahydro-naphthalenylurea derivatives having vanilloid receptor (VR) antagonistic activity
US7582651B2 (en) 2002-07-11 2009-09-01 Takeda Pharmaceutical Company Limited Pyrrolopyridine derivative and use thereof
SE0301446D0 (en) 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds
EP1493438A1 (en) * 2003-07-03 2005-01-05 Bayer HealthCare AG Vanilloid receptor (VR) inhibitors for treatment of Human Immunodeficiency Virus (HIV)-mediated pain states
US7615557B2 (en) 2003-10-01 2009-11-10 Xention Limited Tetrahydro-naphthalene and urea derivatives
JP2007523888A (en) 2003-11-08 2007-08-23 バイエル・ヘルスケア・アクチェンゲゼルシャフト Tetrahydro-quinolinyl urea derivatives
WO2006005472A1 (en) * 2004-07-15 2006-01-19 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with vanilloid receptor 1 (vr1)
AR058705A1 (en) 2005-12-23 2008-02-20 Astrazeneca Ab BENCIMIDAZOL COMPOUNDS AS VANILOID 1 RECEIVER INHIBITORS (VR1)
KR100761222B1 (en) * 2006-03-08 2007-10-04 성균관대학교산학협력단 Vanilloid receptor antagonist for prevention and treatment of drug dependence and addiction
TWI433839B (en) 2006-08-11 2014-04-11 Neomed Inst New benzimidazole derivatives 290
JP2010215563A (en) * 2009-03-17 2010-09-30 Kao Corp Lkb1 activator
CN110876813A (en) * 2019-12-09 2020-03-13 北京大学 Chili horizontal hydrogel and application thereof in repairing peripheral nerve injury and restoring motor function

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4493848A (en) * 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4833138A (en) * 1987-10-23 1989-05-23 Washington University Phenothiazinealkaneamines for treatment of neurotoxic injury
ATE113205T1 (en) * 1988-06-17 1994-11-15 Procter & Gamble APPLICATION OF VANILLIN DERIVATIVES FOR THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF HERPES SIMPLEX INFECTION.
EP0778773A1 (en) * 1994-08-08 1997-06-18 Albert Einstein College Of Medicine Of Yeshiva University Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
FR2740682B1 (en) * 1995-11-06 1997-12-05 Oreal TOPICAL COMPOSITION CONTAINING CAPSAZEPINE
AU5460598A (en) * 1996-11-15 1998-06-03 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists

Also Published As

Publication number Publication date
WO1999000115A1 (en) 1999-01-07
JP2002511866A (en) 2002-04-16
EP1003491A1 (en) 2000-05-31
CA2295089A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
GB9714102D0 (en) Compounds
GB9713484D0 (en) Neuroprotective vanilloid compounds
GB9715584D0 (en) Compounds
GB9710569D0 (en) Compounds
GB9708694D0 (en) Compounds
GB9708805D0 (en) Compounds
GB9709303D0 (en) Compounds
EP0999205A4 (en) Aminocycloalkane compounds
GB9711492D0 (en) Compounds
HUP0004486A3 (en) Neuroprotective agents
GB9712849D0 (en) Compounds
GB9704522D0 (en) Compounds
GB9702978D0 (en) Compounds
GB9705189D0 (en) Compounds
GB9705194D0 (en) Compounds
GB9704490D0 (en) Compounds
GB9704523D0 (en) Compounds
GB9704551D0 (en) Compounds
GB9704579D0 (en) Compounds
GB9704580D0 (en) Compounds
GB9704648D0 (en) Compounds
GB9702646D0 (en) Compounds
GB9704652D0 (en) Compounds
GB9705188D0 (en) Compounds
GB9702608D0 (en) Compounds